Sanjay Das

Sanjay Das

Auto-generated profile, based on publicly available information

Sanjay Das

Durham Veterans Affairs Health Care System, Department of Surgery, Durham, NC; Department of Urology, University of California - Los Angeles, Los Angeles, CA; Department of Urology, Cedars-Sinai Medical Center, Los Angeles

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2023 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
SDSanjay Das
Sanjay Das
LGLin Gu
Lin Gu
CEClaire Trustram Eve
Claire Trustram Eve
JPJoshua Parrish
Joshua Parrish
AHAmanda M. De Hoedt
Amanda M. De Hoedt
SWStephen B. Williams
Stephen B. Williams

15 March 2024 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
SDSanjay Das
Sanjay Das
MLMichael Luu
Michael Luu
MTMartha Terris
Martha Terris
ZKZachary Klaassen
Zachary Klaassen
CKChristopher J. Kane
Christopher J. Kane
TDTimothy J. Daskivich
Timothy J. Daskivich

8 July 2023 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Open access
PDF file
JDJames P. Daniels
James P. Daniels
DPDevin N. Patel
Devin N. Patel
GGGloria Cecilia Galvan
Gloria Cecilia Galvan
NFNadine A. Friedrich
Nadine A. Friedrich
SDSanjay Das
Sanjay Das
SFStephen J. Freedland
Stephen J. Freedland
Understanding patient interest among surgical options is challenging. We used Google Trends to analyze interest in benign prostatic hyperplasia (BPH) surgeries recommended for prostate volumes <80 cc. Google Trends was queried with five BPH surgeries. Final rank of search terms was TURP, UroLift, Rezum, Aquablation, and Greenlight. Google Trends can be an effective tool for evaluating public interest trends in BPH surgery.

1 October 2021 in Urology
Verified
Journal Article
Closed access
MSMichael S. Sessine
Michael S. Sessine
SDSanjay Das
Sanjay Das
BPBumsoo Park
Bumsoo Park
SSSimpa Samuel Salami
Simpa Samuel Salami
SKSamuel D. Kaffenberger
Samuel D. Kaffenberger
TMTodd M Morgan
Todd M Morgan

4 January 2023 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
SDSanjay Das
Sanjay Das
SFStephen J. Freedland
Stephen J. Freedland
Statins are widely prescribed medications that inhibit 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG CoA) reductase and therefore reduce cholesterol synthesis. Given the key role of cholesterol in cancer, statins may therefore have anticancer activities. However, clinical studies investigating the association between statin usage and cancer development have been few and inconsistent. A recent study from Maeda-Minami and colleagues found a significant, though modest, decrease in cancer risk among statin users. However, does this finding mean statin usage directly reduces cancer risk or is merely associated with reduced cancer risk? This editorial analyzes Maeda-Minami and colleagues’ study to provide commentary on statin's proposed role in preventing cancer. See related article, p. 37

8 September 2023 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
SDSanjay Das
Sanjay Das
NFNadine A. Friedrich
Nadine A. Friedrich
JDJames Daniels
James Daniels
GGG. Cecilia Galvan
G. Cecilia Galvan
Jun GongJun Gong
Jun Gong
SFStephen J. Freedland
Stephen J. Freedland